International Journal of Scientific & Technology Research

Home About Us Scope Editorial Board Blog/Latest News Contact Us
10th percentile
Powered by  Scopus
Scopus coverage:
Nov 2018 to May 2020


IJSTR >> Volume 8 - Issue 7, July 2019 Edition

International Journal of Scientific & Technology Research  
International Journal of Scientific & Technology Research

Website: http://www.ijstr.org

ISSN 2277-8616

Hepatitis: The Most Prevalent Liver Disorder In The Lower Socioeconomic Areas Of Karachi, Pakistan

[Full Text]



Maria Arif, Lubna Naz, Amber Ayaz Memon, Zoha Khan, Sakina shabbir, Nazneen Zehra, Ghazala Yasmeen



Liver, Hepatitis, Social class, Infection, inflammation, Viral



Liver diseases are becoming a burden on the world day by day, with viral hepatitis being on top of the list and hepatocellular carcinoma is the 2nd leading cause of cancer deaths. The prime aim of the study was to observe most prevalent Liver disorder in the patients of lower socioeconomic areas. A total of 111 patients were observed in the major government hospitals for various liver disorders. Details of their laboratory parameters including Liver function tests, Hematological factors and ultrasound were collected. Among the 111 patients were categorized based on socioeconomic status, it was found that 82% patients belonged to lower class. For justification, various modifiable risk factors were also observed in these patients including smoking habits, tobacco eating, alcohol consumption, habit of self-medication. From the data collected, it was found that 91.9% patients were diagnosed with Hepatitis, 2.7% patients were diagnosed for Hepatocellular Carcinoma, 1.8% patients were enrolled with hepatomegaly, 1.8% patients were suffering from liver failure while fatty liver and gallstones were the least found liver disorders with only 0.9%. When the patients with hepatitis were categorized, 94.1% were found to be diagnosed with Hepatitis C and rest with Hepatitis B. Hepatitis C was found to be the most prevalent liver disorder in the lower socioeconomic areas of Karachi. Various risk factors were involved in its prevalence Further research, awareness and vaccination programs related to the risk factors and the treatment of Hepatitis are needed to control this life-threatening disease in these areas.



[1]. Juza RM and Pauli EM., (2014). Clinical and surgical anatomy of the liver: a review for clinicians. Clinical Anatomy, 27(5):764-769.
[2]. Farzaei M, Zobeiri M, Parvizi F, El-Senduny F, Marmouzi I, Coy-Barrera E, Naseri R, et al., (2018). Curcumin in liver diseases: A systematic review of the cellular mechanisms of oxidative stress and clinical perspective. Nutrients, 10(7): 855.
[3]. Muriel P. ed. (2017). Liver pathophysiology: therapies and antioxidants. Academic Press.
[4]. Thomas D and Zoulim F., (2012). New challenges in viral hepatitis. Gut, 61(1): i1-i5.
[5]. Harvala H, Wong V, Simmonds P, Johannessen I and Ramalingam S., (2014). Acute viral hepatitis–Should the current screening strategy be modified? Journal of Clinical Virology, 59(3):184-187.
[6]. Malik A. (2016). Over 13 million hepatitis patients in Pakistan. The News. July 28th. Available from: https://www.thenews.com.pk/print/138142-Over-13-million-hepatitis-patients-in-Pakistan
[7]. Sarin SK and Maiwall R., (2012). Global burden of liver disease: a true burden on health sciences and economies. World Gastroenterol Organ, 17(2): 35-40.
[8]. Smith GD, Dorling D, Gordon D and Shaw M., (1999). The widening health gap: what are the solutions? Critical Public Health, 9(2):151-170.
[9]. Najman JM, Toloo G and Siskind V., (2006). Socioeconomic disadvantage and changes in health risk behaviours in Australia: 1989-90 to 2001. Bulletin of the World Health Organization, 84: 976-984.
[10]. Najman JM, Williams GM and Room R., (2007). Increasing socioeconomic inequalities in male cirrhosis of the liver mortality: Australia 1981–2002. Drug and alcohol review, 26(3): 273-278.
[11]. Gilson R and Brook MG., (2006). Hepatitis A, B, and C. Sexually transmitted infections, 82(4): 35-9.
[12]. Lemoine M, Nayagam S and Thursz M., (2013). Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges. Future virology, 8(4): 371-380.
[13]. Gower E, Estes C, Blach S, Razavi-Shearer K and Razavi H., (2014). Global epidemiology and genotype distribution of the hepatitis C virus infection. Journal of hepatology, 61(1): S45-S57.
[14]. Ogholikhan S and Schwarz K., (2016). Hepatitis vaccines. Vaccines, 4(1): 6.
[15]. Lee CH, Chang FC, Hsu SD, Chi HY, Huang LJ and Yeh MK., (2017). Inappropriate self-medication among adolescents and its association with lower medication literacy and substance use. PloS one, 12(12): e0189199.
[16]. Jan A., (2015). Self-medication: A major cause of health Issues. South Asian J Med, 1: 21.
[17]. Giannini EG., Testa R and Savarino V., (2005). Liver enzyme alteration: a guide for clinicians. Cmaj, 172(3): 367-379.
[18]. Shivaraj G, Prakash D, Vinayak H, Avinash M, Sonal V and Shruthi K., (2009). A review on laboratory liver function tests. Pan African Medical Journal, 3.
[19]. Puoti C, Castellacci R and Montagnese F., (2000). Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients? Digestive and Liver Disease, 32(7): 634-643.
[20]. Mohamadnejad M, Pourshams A, Malekzadeh R, Mohamadkhani A, Rajabiani A, Asgari AA, Alimohamadi SM et al., (2003). Healthy ranges of serum alanine aminotransferase levels in Iranian blood donors. World journal of gastroenterology, 9(10): 2322.
[21]. Yaseen MR, Aziz S and Aftab S., (2014). Socio-Economic Factors Affecting Hepatitis C and Lack of Awareness: A Case Study of Pakistan. Iranian journal of public health, 1456-7.